Unlock instant, AI-driven research and patent intelligence for your innovation.

Applications of miR-194-5p

An a-sma, proliferative technology, applied in medical preparations containing active ingredients, organic active ingredients, sensory diseases, etc., can solve the problems of loss, easy recurrence, unclear research, etc., to avoid potential risks and easy to obtain. , cheap effect

Active Publication Date: 2017-10-03
TONGJI UNIV
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the research on the pathogenesis of PVR is still unclear so far. There is no effective treatment drug available clinically, and vitrectomy is still the main treatment, but the operation is relatively complicated, and the operation cannot completely solve the problem. It is easy to relapse after operation, often After multiple operations, the patient's visual function is still gradually declining or even lost, and the operation cost is also very expensive, which brings heavy psychological burden and economic loss to the patient and his family. Drug therapy, to assist the success of retinal detachment surgery, has important clinical significance and social value for the treatment of PVR

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Applications of miR-194-5p
  • Applications of miR-194-5p
  • Applications of miR-194-5p

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] Verification that overexpression of miR-194-5p can inhibit TGFβ1-induced cell migration

[0036] 1. Cell treatment: Cells were seeded in a 96-well plate, transfected with empty vectors psuper and psuper-194-5p 0.1ug each, and transfected with Lipo2000 transfection reagent.

[0037] 2. Scratch: Use a 10uL pipette tip to scratch the cells in the shape of a "one", then wash with PBS 3 times to wash off the floating cells. Add the corresponding treatment medium to continue culturing.

[0038] 3. Take pictures: Take pictures under the microscope at the time points of 0 hour, 24 hours and 48 hours of scratching.

[0039] 4. Data analysis: Use Image J software to measure the width of scratches to obtain width data, and then use Graphpad Prism software for statistical analysis and drawing.

[0040] Microscopic images of ARPE19 cells transfected with pSuper-miR-194-5p and ARPE19 cells with pSuper empty vector at 0 hour, 24 hours and 48 hours of scratching figure 1 , figure ...

Embodiment 2

[0042] Real-time quantitative PCR detection showed that miR-194-5p inhibited the changes of EMT-related markers induced by TGFβ1 at the mRNA level: normal control, TGFβ-treated ARPE19 cells transfected with pSuper-miR-194-5p and pSuper empty vector were treated with 1ml Trizol Collected in a 1.5ml tube for extraction of total RNA. After reverse transcription and real-time quantitative PCR analysis, it was calculated by semi-quantitative method.

[0043] The main steps are as follows:

[0044] 1. Add one-fifth of 200ul volume of chloroform to the sample collected by Trizol, mix vigorously, and centrifuge at 12000rpm at 4°C for 10 minutes.

[0045] 2. After centrifugation, transfer the supernatant to a new centrifuge tube, be careful not to get the protein layer in the middle, and add an equal volume of isopropanol.

[0046] 3. Centrifuge at 12000rpm at 4°C for 10 minutes, discard the supernatant, and wash the precipitate with 75% ethanol 1-2 times.

[0047] 4. After drying t...

Embodiment 3

[0061] Western blot detection showed that miR-194-5p inhibited TGFβ1-induced changes in EMT-related markers at the protein level: Protein extraction was performed on normal control, TGFβ-treated ARPE19 cells transfected with pSuper-miR-194-5p and pSuper empty vector .

[0062] 1. Protein extraction: Inoculate the cells in a 6cm cell culture dish, after corresponding treatment, add 150μl RIPA lysate containing Protease Inhibitor Cocktail, collect the cells into a new EP tube with a cell scraper, and incubate on ice Centrifuge at 10,000 rpm for 30 minutes at 4°C for 15 minutes, gently aspirate the supernatant into a clean centrifuge tube, and store at -80°C for later use.

[0063] 2. Determination of protein concentration: BCA quantitative method was used for protein quantification, and the specific method was as follows: prepare a standard protein solution of 2 μg / μl, and store it at -20°C for later use; The volume ratio of :1 is fully mixed, and it is prepared and used immedi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to the research of proliferative vitreoretinopathy (PVR), particularly to applications of miR-194-5p as a proliferative vitreoretinopathy treatment drug. According to the present invention, through in vitro cell models and animal PVR models, it is proved that miR-194-5p can effectively inhibit the main pathological change process epithelium-interstitial tissue transformation of PVR in vivo and in vitro, and the small molecule compound can be subjected to local ocular application through intravitreal injection, cannot produce other side effects caused by systemic administration, and is expected to become the effective PVR treatment drug for assisting retinal detachment surgery; and the miR-194-5p acts by down-regulating Zeb1.

Description

technical field [0001] The present invention relates to the research of proliferative vitreoretinopathy (PVR), in particular to the application of miR-194-5p as a therapeutic drug for proliferative vitreoretinopathy. Background technique [0002] Proliferative vitreoretinopathy (PVR) refers to lesions in which the membranes in the vitreous cavity and on the retinal surface proliferate and shrink after rhegmatogenous retinal detachment. Distortion and occlusion of the macula, while PVR is also the most common cause of failure of retinal detachment surgery, the reported incidence rate is 5.1% to 11.7%, in the final failed retinal detachment surgery, 75% of the causes are attributed to PVR, It is therefore also a major cause of blindness. It is reported in the literature that only 11-25% of PVR patients can achieve visual acuity above 0.2 after treatment. However, the research on the pathogenesis of PVR is still unclear so far. There is no effective treatment drug available c...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/7105A61P27/02
CPCA61K31/7105
Inventor 吕立夏徐国彤
Owner TONGJI UNIV